Skip to main content

Glaxo Expects a Shot of Growth in 2013: CEO

GlaxoSmithKline expects a return to growth in 2013 after the drugmaker's profits slipped in 2012 as austerity pricing in Europe continued to bite, CEO Andrew Witty told CNBC's "Squawk on the Street" on Wednesday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.